BDO USA

Analysis: Biotechs continue to invest in R&D

Friday, September 13, 2013

Amid a robust period in the biotech industry, R&D spending continues to rise. According to the third annual study from accounting and consulting firm BDO USA, average R&D expenditure among biotechs increased 8% in 2012, compared to a 4% increase in 2011.

[Read More]